Age does not appear to affect efficacy of siponimod in secondary progressive MSMarch 10, 2020Multiple Sclerosis
How often do neurologists escalate MS therapy after detecting MRI activity?February 29, 2020Multiple Sclerosis
Eculizumab reduces relapse-related hospitalizations in patients with NMOSDFebruary 29, 2020Multiple Sclerosis
